Ehsan Chitsaz

854 total citations
40 papers, 635 citations indexed

About

Ehsan Chitsaz is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Ehsan Chitsaz has authored 40 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 19 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Ehsan Chitsaz's work include Tuberculosis Research and Epidemiology (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers) and Infectious Diseases and Tuberculosis (6 papers). Ehsan Chitsaz is often cited by papers focused on Tuberculosis Research and Epidemiology (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers) and Infectious Diseases and Tuberculosis (6 papers). Ehsan Chitsaz collaborates with scholars based in Iran, United States and China. Ehsan Chitsaz's co-authors include Payam Tabarsi, Davood Mansouri, Mohammad Reza Masjedi, Parvaneh Baghaei, Parissa Farnia, Majid Marjani, Ali Akbar Velayati, Mehdi Kazempour Dizaji, Mehdi Mirsaeidi and Masoud Shamaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Ehsan Chitsaz

36 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Chitsaz Iran 17 414 387 215 38 36 40 635
Valéria C. Rolla Brazil 18 574 1.4× 453 1.2× 262 1.2× 89 2.3× 58 1.6× 69 951
Susan Szabo United States 16 366 0.9× 308 0.8× 132 0.6× 31 0.8× 6 0.2× 55 871
Padmanesan Narasimhan Australia 13 445 1.1× 296 0.8× 145 0.7× 3 0.1× 173 4.8× 32 846
Fuad Mirzayev Switzerland 11 543 1.3× 386 1.0× 215 1.0× 13 0.3× 19 0.5× 25 704
Marcela Muñóz-Torrico Mexico 16 724 1.7× 459 1.2× 207 1.0× 25 0.7× 43 1.2× 30 1.0k
José Molero Spain 15 145 0.4× 71 0.2× 36 0.2× 15 0.4× 51 1.4× 96 795
Paul Leger United States 15 517 1.2× 181 0.5× 45 0.2× 26 0.7× 23 0.6× 31 738
Chi‐Chiu Leung China 18 618 1.5× 476 1.2× 242 1.1× 159 4.2× 35 1.0× 29 904
Mano Selvan United States 12 188 0.5× 137 0.4× 106 0.5× 3 0.1× 28 0.8× 21 616
Jonah Musa Nigeria 14 110 0.3× 380 1.0× 83 0.4× 3 0.1× 76 2.1× 73 680

Countries citing papers authored by Ehsan Chitsaz

Since Specialization
Citations

This map shows the geographic impact of Ehsan Chitsaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Chitsaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Chitsaz more than expected).

Fields of papers citing papers by Ehsan Chitsaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Chitsaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Chitsaz. The network helps show where Ehsan Chitsaz may publish in the future.

Co-authorship network of co-authors of Ehsan Chitsaz

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Chitsaz. A scholar is included among the top collaborators of Ehsan Chitsaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Chitsaz. Ehsan Chitsaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chitsaz, Ehsan, et al.. (2020). Competition Shadow: Anchoring to Fear Versus Hope in Estimating Rivals in Competition. Advances in Cognitive Psychology. 16(3). 186–201. 2 indexed citations
3.
Chitsaz, Ehsan, et al.. (2019). The Effect of Human and Social Capital on Entrepreneurial Activities: A Case Study of Iran and Implications. Journal of Entrepreneurship and Sustainability Issues. 6(3). 1393–1403. 41 indexed citations
4.
Chitsaz, Ehsan, et al.. (2018). Black Smoke Arising in the Duodenum After Liver Biopsy: What Does the Smoke Signal Mean?. Gastroenterology. 155(3). e1–e2. 1 indexed citations
5.
Chitsaz, Ehsan, et al.. (2018). “Dwarfing” White Strands on Screening Colonoscopy!. Gastroenterology. 155(3). e22–e23. 2 indexed citations
6.
Chitsaz, Ehsan, et al.. (2016). The impact of resource configuration on Iranian technology venture performance. Technological Forecasting and Social Change. 122. 186–195. 24 indexed citations
7.
Chitsaz, Ehsan, Jaimie P. Meyer, Archana Krishnan, et al.. (2013). Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail. AIDS and Behavior. 17(S2). 118–127. 52 indexed citations
8.
Sharif-Kashani, Babak, et al.. (2012). Wells’ prediction rules for pulmonary embolism. Blood Coagulation & Fibrinolysis. 23(7). 614–618. 2 indexed citations
9.
Tabarsi, Payam, et al.. (2012). Treatment outcome and mortality: Their predictors among HIV/TB co-infected patients from Iran. SHILAP Revista de lepidopterología. 1(2). 82–86. 8 indexed citations
10.
Bikdeli, Behnood, et al.. (2011). Dexter versus Sinister Deep Vein Thrombosis: Which Is the More Sinister? Findings from the NRITLD DVT Registry. Seminars in Thrombosis and Hemostasis. 37(3). 298–304. 8 indexed citations
11.
Beyhaghi, Hadi, et al.. (2010). THE APPROPRIATE APPROACH FOR ADOPTION OF CLINICAL PRACTICE GUIDELINES IN THE NATIONAL HEALTH SYSTEM, ACCORDING TO THE EXPERIENCED PROJECT IN IRAN NATIONAL HEALTH SYSTEM. 13(1). 49–57. 4 indexed citations
12.
Marjani, Majid, Payam Tabarsi, Parvaneh Baghaei, et al.. (2010). SMOKING EFFECTS ON CLINICAL MANIFESTATIONS AND DRUG RESISTANCE PATTERNS IN PULMONARY TB PATIENTS. 9(4). 53–60. 3 indexed citations
13.
Tabarsi, Payam, Ehsan Chitsaz, Parvaneh Baghaei, et al.. (2010). Revised Category II Regimen as an Alternative Strategy for Retreatment of Category I Regimen Failure and Irregular Treatment Cases. American Journal of Therapeutics. 18(5). 343–349. 12 indexed citations
14.
Baghaei, Parvaneh, Payam Tabarsi, Ehsan Chitsaz, et al.. (2010). Incidence, Clinical and Epidemiological Risk Factors, and Outcome of Drug-Induced Hepatitis Due to Antituberculous Agents in New Tuberculosis Cases. American Journal of Therapeutics. 17(1). 17–22. 42 indexed citations
15.
Tabarsi, Payam, Ehsan Chitsaz, Parvaneh Baghaei, et al.. (2010). Impact of Extensively Drug-Resistant Tuberculosis on Treatment Outcome of Multidrug-Resistant Tuberculosis Patients with Standardized Regimen: Report from Iran. Microbial Drug Resistance. 16(1). 81–86. 18 indexed citations
16.
17.
Baghaei, Parvaneh, et al.. (2009). RISK FACTORS ASSOCIATED WITH MULTIDRUG-RESISTANT TUBERCULOSIS. 8(3). 17–21. 26 indexed citations
18.
Shamaei, Masoud, Majid Marjani, Ehsan Chitsaz, et al.. (2009). First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance. International Journal of Infectious Diseases. 13(5). e236–e240. 71 indexed citations
19.
Tabarsi, Payam, Parvaneh Baghaei, Parissa Farnia, et al.. (2008). Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study. Scandinavian Journal of Infectious Diseases. 41(1). 10–13. 6 indexed citations
20.
Masjedi, Mohammad Reza, Payam Tabarsi, Ehsan Chitsaz, & Ali Akbar Velayati. (2008). Outcome of Treatment of MDR-TB Patients with Standardized Regimens; Iran's Experience 2002–2006. International Journal of Infectious Diseases. 12. e250–e251. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valéria C. Rolla Breakdown of academic impact, for papers by Susan Szabo Breakdown of academic impact, for papers by Padmanesan Narasimhan Breakdown of academic impact, for papers by Fuad Mirzayev Breakdown of academic impact, for papers by Marcela Muñóz-Torrico Breakdown of academic impact, for papers by José Molero Breakdown of academic impact, for papers by Paul Leger Breakdown of academic impact, for papers by Chi‐Chiu Leung Breakdown of academic impact, for papers by Mano Selvan Breakdown of academic impact, for papers by Jonah Musa
Rankless by CCL
2026